BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26296350)

  • 1. Characterization of lethal dengue virus type 4 (DENV-4) TVP-376 infection in mice lacking both IFN-α/β and IFN-γ receptors (AG129) and comparison with the DENV-2 AG129 mouse model.
    Sarathy VV; Infante E; Li L; Campbell GA; Wang T; Paessler S; Robert Beatty P; Harris E; Milligan GN; Bourne N; Barrett ADT
    J Gen Virol; 2015 Oct; 96(10):3035-3048. PubMed ID: 26296350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease.
    Sarathy VV; White M; Li L; Gorder SR; Pyles RB; Campbell GA; Milligan GN; Bourne N; Barrett AD
    J Virol; 2015 Jan; 89(2):1254-66. PubMed ID: 25392217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse models of dengue virus infection for vaccine testing.
    Sarathy VV; Milligan GN; Bourne N; Barrett AD
    Vaccine; 2015 Dec; 33(50):7051-60. PubMed ID: 26478201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a murine model of non-lethal, symptomatic dengue virus infection.
    Sarathy VV; White M; Li L; Kaiser JA; Campbell GA; Milligan GN; Bourne N; Barrett ADT
    Sci Rep; 2018 Mar; 8(1):4900. PubMed ID: 29559699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A lethal model of disseminated dengue virus type 1 infection in AG129 mice.
    Milligan GN; Sarathy VV; White MM; Greenberg MB; Campbell GA; Pyles RB; Barrett ADT; Bourne N
    J Gen Virol; 2017 Oct; 98(10):2507-2519. PubMed ID: 28949904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma interferon (IFN-γ) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-α/β receptor-deficient mice.
    Prestwood TR; Morar MM; Zellweger RM; Miller R; May MM; Yauch LE; Lada SM; Shresta S
    J Virol; 2012 Dec; 86(23):12561-70. PubMed ID: 22973027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.
    Züst R; Toh YX; Valdés I; Cerny D; Heinrich J; Hermida L; Marcos E; Guillén G; Kalinke U; Shi PY; Fink K
    J Virol; 2014 Jul; 88(13):7276-85. PubMed ID: 24741106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice.
    Milligan GN; Sarathy VV; Infante E; Li L; Campbell GA; Beatty PR; Harris E; Barrett AD; Bourne N
    PLoS One; 2015; 10(5):e0125476. PubMed ID: 25938762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor.
    Perry ST; Buck MD; Lada SM; Schindler C; Shresta S
    PLoS Pathog; 2011 Feb; 7(2):e1001297. PubMed ID: 21379341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infant mouse brain passaged Dengue serotype 2 virus induces non-neurological disease with inflammatory spleen collapse in AG129 mice after splenic adaptation.
    Rajmane Y; Shaikh S; Basha K; Reddy GE; Nair S; Kamath S; Sreejesh G; Rao H; Ramana V; Kumar AS
    Virus Res; 2013 May; 173(2):386-97. PubMed ID: 23337909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence diversity of dengue virus type 2 in brain and thymus of infected interferon receptor ko mice: implications for dengue virulence.
    Dhole P; Nakayama EE; Saito A; Limkittikul K; Phanthanawiboon S; Shioda T; Kurosu T
    Virol J; 2016 Nov; 13(1):199. PubMed ID: 27903277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Systemic Infection with Dengue Virus Leads to Vascular Leakage and Death through Tumor Necrosis Factor-α and Tie2/Angiopoietin Signaling in Mice Lacking Type I and II Interferon Receptors.
    Phanthanawiboon S; Limkittikul K; Sakai Y; Takakura N; Saijo M; Kurosu T
    PLoS One; 2016; 11(2):e0148564. PubMed ID: 26844767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor.
    Orozco S; Schmid MA; Parameswaran P; Lachica R; Henn MR; Beatty R; Harris E
    J Gen Virol; 2012 Oct; 93(Pt 10):2152-2157. PubMed ID: 22815273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFN-γ production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner.
    Fagundes CT; Costa VV; Cisalpino D; Amaral FA; Souza PR; Souza RS; Ryffel B; Vieira LQ; Silva TA; Atrasheuskaya A; Ignatyev G; Sousa LP; Souza DG; Teixeira MM
    PLoS Negl Trop Dis; 2011 Dec; 5(12):e1449. PubMed ID: 22206036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non mouse-adapted dengue virus strain as a new model of severe dengue infection in AG129 mice.
    Tan GK; Ng JK; Trasti SL; Schul W; Yip G; Alonso S
    PLoS Negl Trop Dis; 2010 Apr; 4(4):e672. PubMed ID: 20436920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
    Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
    J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models.
    Tang WW; Grewal R; Shresta S
    Curr Opin Virol; 2015 Aug; 13():61-6. PubMed ID: 26001278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing antiviral compounds in a dengue mouse model.
    Schul W; Yip A; Shi PY
    Methods Mol Biol; 2013; 1030():269-81. PubMed ID: 23821275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses.
    Carlin AF; Plummer EM; Vizcarra EA; Sheets N; Joo Y; Tang W; Day J; Greenbaum J; Glass CK; Diamond MS; Shresta S
    Cell Rep; 2017 Nov; 21(6):1600-1612. PubMed ID: 29117564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice.
    Fuchs J; Chu H; O'Day P; Pyles R; Bourne N; Das SC; Milligan GN; Barrett AD; Partidos CD; Osorio JE
    Vaccine; 2014 Nov; 32(48):6537-43. PubMed ID: 25239488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.